Alliance Wealth Advisors LLC UT Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Alliance Wealth Advisors LLC UT lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,495 shares of the healthcare conglomerate’s stock after purchasing an additional 69 shares during the quarter. UnitedHealth Group comprises about 1.0% of Alliance Wealth Advisors LLC UT’s holdings, making the stock its 28th biggest holding. Alliance Wealth Advisors LLC UT’s holdings in UnitedHealth Group were worth $2,893,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after buying an additional 527,526 shares during the period. Northern Trust Corp boosted its stake in UnitedHealth Group by 3.6% during the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after buying an additional 341,749 shares during the period. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.2% during the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after buying an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of UnitedHealth Group by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after purchasing an additional 27,127 shares in the last quarter. Finally, Sanders Capital LLC lifted its position in shares of UnitedHealth Group by 6.5% during the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after purchasing an additional 352,710 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on UNH. TD Cowen reduced their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Barclays raised their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Performance

Shares of UNH traded up $1.49 during mid-day trading on Friday, reaching $495.35. 2,727,016 shares of the company’s stock were exchanged, compared to its average volume of 5,623,667. The business’s fifty day simple moving average is $485.84 and its 200-day simple moving average is $514.21. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The stock has a market capitalization of $455.76 billion, a PE ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the firm posted $6.26 EPS. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.